Clifford Chance advised Sanofi on the deal. Global healthcare company Sanofi announced the acquisition of exclusive rights to develop and commercialise aficamten in Greater China from...
Sanofi’s Acquisition Of Aficamten Rights From Corxel Pharmaceuticals
Sanofi’s Acquisition Of Aficamten Rights From Corxel Pharmaceuticals
Clifford Chance advised Sanofi on the deal. Global healthcare company Sanofi announced the acquisition of exclusive rights to develop and commercialise aficamten in Greater China from...
CBC Group and Mubadala’s Acquisition Of UCB’s Mature Business In China
On the deal, Clifford Chance and Mourant advised CBC Group and Mubadala; Cleary Gottlieb acted as onshore legal advisors to Mubadala. CBC Group, Asia’s largest healthcare-dedicated...



























